Announced
Completed
Gilead Sciences completed a $45m investment in Assembly Biosciences.
Synopsis
Gilead Sciences, a biopharmaceutical company, completed a $45m investment in Assembly Biosciences, a clinical-stage biotechnology company.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite